Introduction Peptide therapies have rapidly entered mainstream musculoskeletal culture, driven by social media promotion, direct-to-consumer wellness and optimization clinics, and the expanding commercialization of biologic optimization (Vasireddi et al
Novo Nordisk has been investigating CagriSema through the REDEFINE programme, a series of Phase 3 clinical trials in adults with overweight or obesity
CJC-1295 is typically dosed at 1-2 mg per week
Patients commonly see redness at the treatment site immediately following treatment which fades within 1-2 days, and are recommended to protect their treated areas from sun exposure for at least 2 weeks following treatment
Patients with LRRK2 gene mutation can be great candidates for Vit B12 supplementation (Obeid and Herrmann 2006)
Therefore, most Americans have more than enough vitamin B12 in their systems and do not need to worry about increasing their B12 levels